Topic: Pharmaceuticals Industry

This photo taken Thursday, July 9, 2015, is the headquarters of Gilead Sciences in Foster City, Calif. Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions filled for hepatitis-C drugs in the first three months of this year, according to IMS Health. (AP Photo/Eric Risberg)

We already paid for COVID-19 treatments

Alex Lawson - Independent Media Institute